-
Investors gravitating toward startup device companies: 5 transactions to know
Under-the-radar spine and orthopedic device companies have garnered multimillion-dollar funding rounds from investors in recent months. -
Dr. Jay Keener debuts Stryker's new shoulder replacement implant
Jay Keener, MD, an orthopedic surgeon in St. Louis, performed the first case with Stryker's Tornier patient-matched glenoid implant. -
Amber Implants closes $10M series A financing round
Amber Implants recently closed a $10 million series A financing round, the spinal implant company said Jan. 19. -
Implanet revenue grew 58% last year
Global medical technology company Implanet saw a 58 percent increase in revenue in 2021, the company said Jan. 18. -
Nevro's spine stimulation system to treat back pain cleared by FDA
Medical device company Nevro received FDA approval to use its Senza spinal cord stimulation system to treat nonsurgical refractory back pain, the company said Jan. 19. -
Smith+Nephew acquires cementless partial knee system for $135M
Smith+Nephew acquired Engage Surgical, which has the only cementless partial knee system commercially available in the U.S. -
2 CEO moves, promising spinal cord stimulation data & more: 8 device company notes
Augmedics' new CEO and seven more updates from spine and orthopedic device companies in the last week: -
Orthofix partners to develop AI guidance systems
Orthofix and nView Medical have partnered to develop and co-market artificial intelligence-driven guidance systems for spine and orthopedic cases. -
Spine device company sees milestone growth in sacroiliac joint division
Austin-based devicemaker Genesys Spine reported 184 percent year-over-year revenue growth in its sacroiliac joint division in 2021. -
Hip Innovation Technology gets green light to study reverse hip system
Hip Innovation Technology received FDA approval to start a clinical study examining its reverse hip replacement system. -
Vuze's spinal stabilization surgery system gets FDA clearance
Vuze Medical's proprietary software-only guidance system received FDA 510(k) clearance. -
Augmedics names new CEO
Augmedics, which develops the Xvision augmented reality surgical system, named Kevin Hykes president and CEO. -
New president, CEO takes helm at orthopedic device company
Catalyst OrthoScience, a medtech company focused on the upper extremity orthopedics market, has appointed Carl O'Connell president and CEO. -
AI-driven augmented reality spine system gets green light
Surgalign Holdings received FDA 510(k) clearance for its Holo Portal surgical system for lumbar spine surgeries. -
Medtronic's spinal cord stimulation shows strong pain relief results
Medtronic's spinal cord stimulation therapy system showed meaningful pain relief results in a three-month study, the medical device company said Jan. 14. -
Paragon 28 acquires preoperative planning company
Paragon 28, a foot and ankle devicemaker, acquired software company Disior. -
Medtronic's recall, Stryker's $3.1B acquisition & more: 8 medtech notes
Stryker's multibillion-dollar acquisition, Nexus Spine's newest leadership hires and six more updates from spine and orthopedic device companies in the last week: -
14 spine devices approved by FDA in December
The FDA granted 24 spine devices clearance in December. -
Hand Biomechanics Lab launches disposable blade assembly for carpal tunnel surgeries
Medical device company Hand Biomechanics Lab recently launched a blade assembly device for use in endoscopic carpal tunnel release. -
Catalyst OrthoScience names president, CEO
Catalyst OrthoScience, which focuses on upper extremity orthopedic devices, named Carl O'Connell president and CEO.
Page 45 of 190